Cargando…

Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains

BACKGROUND: Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent of enzootic pneumonia in pigs. Pigs are often infected with different M. hyopneumoniae strains. This study assessed the efficacy of vaccination against experimental infection with two genetically different M. hyopneumoniae...

Descripción completa

Detalles Bibliográficos
Autores principales: Michiels, Annelies, Arsenakis, Ioannis, Boyen, Filip, Krejci, Roman, Haesebrouck, Freddy, Maes, Dominiek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576127/
https://www.ncbi.nlm.nih.gov/pubmed/28851359
http://dx.doi.org/10.1186/s12917-017-1195-0
_version_ 1783260149077508096
author Michiels, Annelies
Arsenakis, Ioannis
Boyen, Filip
Krejci, Roman
Haesebrouck, Freddy
Maes, Dominiek
author_facet Michiels, Annelies
Arsenakis, Ioannis
Boyen, Filip
Krejci, Roman
Haesebrouck, Freddy
Maes, Dominiek
author_sort Michiels, Annelies
collection PubMed
description BACKGROUND: Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent of enzootic pneumonia in pigs. Pigs are often infected with different M. hyopneumoniae strains. This study assessed the efficacy of vaccination against experimental infection with two genetically different M. hyopneumoniae strains in weaned piglets. At 33 days of age (D0), 45 M. hyopneumoniae-free piglets were randomly assigned to three different groups: 1) negative control group (NCG; n = 5): not vaccinated, not infected, 2) positive control group (PCG; n = 20): not vaccinated, infected, and 3) vaccination group (VG; n = 20): single vaccination with an inactivated whole-cell M. hyopneumoniae vaccine (Hyogen®, Ceva) (D1), infected. The PCG and VG were endotracheally inoculated with 7 × 10(7) CCU in 7 ml of the highly virulent M. hyopneumoniae strain F7.2C (D24) and 7 × 10(7) CCU in 7 ml low virulent strain F1.12A (D25). A respiratory disease score (RDS) was assessed from D24 until D53. At D53 (euthanasia), macroscopic lung lesions (MLL) were scored, log copies of M. hyopneumoniae DNA (qPCR) and IL-1 and IL-6-concentrations (ELISA) on bronchoalveolar lavage fluid were determined. RESULTS: The RDS and MLL at euthanasia were respectively 0, 1.20 and 0.55 (P < 0.001) and 0, 7.56 and 0.68 (P < 0.001) for NCG, PCG and VG, respectively. The qPCR results for PCG and VG were 3.99 and 1.78 log copies (P < 0.001), respectively, with a significant difference between PCG and VG. The IL-1 and IL-6 results at euthanasia for NCG, PCG and VG were 17.61, 1283.39 and 53.04 pg/ml (P < 0.001) and 148.10, 493.35 and 259.80 pg/ml (P = 0.004), respectively with a significant difference between PCG and VG. CONCLUSIONS: Vaccination with Hyogen® in pigs was efficacious against an experimental challenge with both a low and highly virulent M. hyopneumoniae strain as the vaccinated pigs coughed significantly less, and showed significantly less lung lesions compared to the non-vaccinated challenged pigs: the vaccinated animals showed a 52.9% lower RDS and 91.0% lower MLL compared to the PCG. In the bronchoalveolar lavage fluid collected at the necropsy of the vaccinated pigs, a significantly lower amount of M. hyopneumoniae-DNA and a significantly lower IL-1 and IL-6 concentration was found compared to the pigs of the PCG.
format Online
Article
Text
id pubmed-5576127
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55761272017-08-30 Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains Michiels, Annelies Arsenakis, Ioannis Boyen, Filip Krejci, Roman Haesebrouck, Freddy Maes, Dominiek BMC Vet Res Research Article BACKGROUND: Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary agent of enzootic pneumonia in pigs. Pigs are often infected with different M. hyopneumoniae strains. This study assessed the efficacy of vaccination against experimental infection with two genetically different M. hyopneumoniae strains in weaned piglets. At 33 days of age (D0), 45 M. hyopneumoniae-free piglets were randomly assigned to three different groups: 1) negative control group (NCG; n = 5): not vaccinated, not infected, 2) positive control group (PCG; n = 20): not vaccinated, infected, and 3) vaccination group (VG; n = 20): single vaccination with an inactivated whole-cell M. hyopneumoniae vaccine (Hyogen®, Ceva) (D1), infected. The PCG and VG were endotracheally inoculated with 7 × 10(7) CCU in 7 ml of the highly virulent M. hyopneumoniae strain F7.2C (D24) and 7 × 10(7) CCU in 7 ml low virulent strain F1.12A (D25). A respiratory disease score (RDS) was assessed from D24 until D53. At D53 (euthanasia), macroscopic lung lesions (MLL) were scored, log copies of M. hyopneumoniae DNA (qPCR) and IL-1 and IL-6-concentrations (ELISA) on bronchoalveolar lavage fluid were determined. RESULTS: The RDS and MLL at euthanasia were respectively 0, 1.20 and 0.55 (P < 0.001) and 0, 7.56 and 0.68 (P < 0.001) for NCG, PCG and VG, respectively. The qPCR results for PCG and VG were 3.99 and 1.78 log copies (P < 0.001), respectively, with a significant difference between PCG and VG. The IL-1 and IL-6 results at euthanasia for NCG, PCG and VG were 17.61, 1283.39 and 53.04 pg/ml (P < 0.001) and 148.10, 493.35 and 259.80 pg/ml (P = 0.004), respectively with a significant difference between PCG and VG. CONCLUSIONS: Vaccination with Hyogen® in pigs was efficacious against an experimental challenge with both a low and highly virulent M. hyopneumoniae strain as the vaccinated pigs coughed significantly less, and showed significantly less lung lesions compared to the non-vaccinated challenged pigs: the vaccinated animals showed a 52.9% lower RDS and 91.0% lower MLL compared to the PCG. In the bronchoalveolar lavage fluid collected at the necropsy of the vaccinated pigs, a significantly lower amount of M. hyopneumoniae-DNA and a significantly lower IL-1 and IL-6 concentration was found compared to the pigs of the PCG. BioMed Central 2017-08-29 /pmc/articles/PMC5576127/ /pubmed/28851359 http://dx.doi.org/10.1186/s12917-017-1195-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Michiels, Annelies
Arsenakis, Ioannis
Boyen, Filip
Krejci, Roman
Haesebrouck, Freddy
Maes, Dominiek
Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains
title Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains
title_full Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains
title_fullStr Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains
title_full_unstemmed Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains
title_short Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains
title_sort efficacy of one dose vaccination against experimental infection with two mycoplasma hyopneumoniae strains
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576127/
https://www.ncbi.nlm.nih.gov/pubmed/28851359
http://dx.doi.org/10.1186/s12917-017-1195-0
work_keys_str_mv AT michielsannelies efficacyofonedosevaccinationagainstexperimentalinfectionwithtwomycoplasmahyopneumoniaestrains
AT arsenakisioannis efficacyofonedosevaccinationagainstexperimentalinfectionwithtwomycoplasmahyopneumoniaestrains
AT boyenfilip efficacyofonedosevaccinationagainstexperimentalinfectionwithtwomycoplasmahyopneumoniaestrains
AT krejciroman efficacyofonedosevaccinationagainstexperimentalinfectionwithtwomycoplasmahyopneumoniaestrains
AT haesebrouckfreddy efficacyofonedosevaccinationagainstexperimentalinfectionwithtwomycoplasmahyopneumoniaestrains
AT maesdominiek efficacyofonedosevaccinationagainstexperimentalinfectionwithtwomycoplasmahyopneumoniaestrains